Fundraising FoxBreye Therapeutics
3 known investors
Find your way into Breye Therapeutics
Sign up to see every warm intro you have to Breye Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Breye Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Breye Therapeutics is a biopharmaceutical company developing medicines for ophthalmologic and metabolic diseases, leveraging expertise in clinical development, manufacturing, and regulatory pathways. The company focuses on bringing novel therapies from early-stage discovery through late-stage development and product approval.
Founders & leadership
UM
Ulrik MouritzenCEO
Investors · 3
Novo Holdings✓ confirmed by Breye TherapeuticsHellerup · $1.1M – $54M
How we know: the company's own site · Not right? Tell us
Modi Ventureslisted by Modi VenturesHouston
How we know: Modi Ventures's portfolio page · Not right? Tell us
Sound BioventuresreportedMalmö
How we know: the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does Breye Therapeutics do?
- Breye Therapeutics is a biopharmaceutical company developing medicines for ophthalmologic and metabolic diseases, leveraging expertise in clinical development, manufacturing, and regulatory pathways. The company focuses on bringing novel therapies from early-stage discovery through late-stage development and product approval.
- Who are Breye Therapeutics's investors?
- Breye Therapeutics's investors include Novo Holdings, Modi Ventures, Sound Bioventures.